[The efficacy of S-1 monotherapy as a 2nd/3rd-line therapy for unresectable recurrent colon cancer: Kanagawa conference of clinical oncology (KCCO)].

Source:http://linkedlifedata.com/resource/pubmed/id/19838025

Download in:

View as

General Info

PMID
19838025